Bioavailability of sediment-associated contaminants was assessed in parallel tests by means of a bivalve (Macoma nasuta) bioaccumulation assay and a novel in vitro digestive fluid extraction procedure. Digestive fluid was obtained from the deposit-feeding polychaete Arenicola brasiliensis and used to extract sediments from a U.S. Navy facility. Both the digestive fluid extraction and the bivalve bioaccumulation test identified Cd, Pb, high molecular weight polycyclic aromatic hydrocarbons (HPAHs), and polychlorinated biphenyls (PCBs) as the contaminants of concern; both procedures indicated that As, Cu, Hg, Ni, Zn, and low molecular weight polycyclic aromatic hydrocarbons were rarely, if ever, of concern. The only contaminant for which the techniques consistently differed was Cr, a result attributable to constraints on intestinal absorption of the metal by the bivalves. For Cd and Pb, the concentration attained in digestive fluid during a brief extraction was highly correlated with concentration attained in the bivalve after a 28-d exposure; correlation was marginal for HPAHs and was nonsignificant for PCBs. However, bulk sediment concentrations were equally good predictors of bioaccumulation because of minimal differences in bioavailability from the most contaminated sediments. In vitro contaminant extraction with the digestive fluid assay has potential as a screening tool to predict relative bioaccumulation risk, and has several advantages over traditional tests.